At the 2026 Chengdu municipal "two sessions" — the city’s high-profile annual political meetings — a clutch of locally made artificial-intelligence products took centre stage alongside policy debates about jobs and services. Among humanoid robots and smart glasses, one unassuming object drew particular attention: an AI-enabled health hat developed by BrainHealth Spectrum (Chengdu) AI Technology Co., which merges multispectral photodynamic technology with AI models in a lightweight, wearable form.
Delegates who tried the device focused less on novelty and more on the engineering behind it: the company’s ability to integrate advanced optics, clinical data and compact algorithms into a consumer-facing product. Organisers and company officials highlighted Chengdu’s complementary industrial strengths — national-level computing resources, deep clinical networks and a mature medical-device supply chain — as the reason such a translation from lab to market was possible at speed.
The firm reports a sharp commercial uptick: orders in the opening weeks of the year are roughly double those of the same period last year, and exports now reach more than 30 countries. Its stated strategy is to deepen investment in base technologies and data models while broadening the product line into portable and home-use devices so that specialist spectral techniques can move out of hospitals and into everyday health monitoring.
Local officials and company representatives framed the device as emblematic of Chengdu’s broader "AI+" push, where municipal policies open application scenarios and expedite technical validation. The city’s pitch to businesses is straightforward: combine national compute power with local manufacturing and clinical ecosystems to accelerate commercialisation and exports — a model that appears to be delivering early results for at least one startup.
For outside observers, the spectacle at Chengdu’s meetings illustrates two trends. First, Chinese regional governments are actively shaping industrial pathways for AI, using targeted support and existing sector strengths to create home-grown specialisations. Second, medical and consumer technologies that fuse hardware, optics and AI are moving faster to market, raising both commercial opportunities and questions about clinical validation, regulation and cross-border acceptance.